期刊文献+

改良小梁切除术后早期并发症的临床观察

EARLY COMPLICATIONS AFTER MODIFIED TRABECULECTOMY:A CLINICAL OBSERVATION
下载PDF
导出
摘要 目的探讨改良小梁切除术后早期并发症的发生原因、治疗方法及效果。方法2006年1月~2007年12月,在我院行改良小梁切除术的各种类型青光眼住院病人共122例(132眼)。术中使用抗代谢药物丝裂霉素C抑制滤过区瘢痕形成,并采用巩膜瓣可调整缝线控制术后浅前房或无前房,以获得功能型滤过泡和理想的眼压控制。结果改良小梁切除术后早期并发症的发生率为19.70%,其中浅前房20眼(15.15%),前房混血4眼(3.03%),一过性高眼压1眼(0.76%),一过性低眼压1眼(0.76%)。对术后发生早期并发症的26眼中的23眼采取保守治疗,治愈21眼(91.30%)。结论改良小梁切除术后早期并发症的保守治疗效果显著。明确青光眼改良小梁切除术后常见并发症的原因,采取有效的措施积极处理,可降低手术风险,减少术后并发症,取得令人满意的效果。 Objective To investigate the causes, treatment and its outcome of early complications after modified trabeculectomy. Methods From Jan. 2006 to Dec. 2007, 132 eyes in 122 patients received modified trabeculectomy for various-type glaucoma. Mitomycin C was used to prevent scarring, adjustable suture used to get functional filtration vesicle and control intraocular pressure. Results The incidence of early postoperative complications was 19.70%, in which, shallow anterior chamber 20 eyes (15.15%) ; anterior chamber bleeding four eyes (3.03%) ; transient ocular hypertension and hypotension one eye, respectively (0. 76% and 0. 76%). Of the 26 eyes with complications, 23 were treated conservatively, 21 were cured. Conclusion The efficacy of conservative therapy for early complications after this surgery is notable. Identifying the causes of complications and conducting active management may reduce the risk of surgery.
出处 《齐鲁医学杂志》 2009年第2期121-124,共4页 Medical Journal of Qilu
关键词 青光眼 小梁切除术 手术后并发症 丝裂霉素C Glaucoma Trabeculectomy Postoperative complications Mitomycin C
  • 相关文献

参考文献10

  • 1EDMUNDS B, THOMPSON J R, SALMON J F, et al. The national survey of trabeculectomy, Ⅲ. Early and late complications[J]. Eye, 2002,16(3) :297-303.
  • 2KRONFELD P C. The chemical demonstration of transeonjunctival passage of aqueous after antiglaucomatous operations [J]. Am J Ophthalmol, 1952,35(1) :38-45.
  • 3SPAETH G L. Ophthalmic surgery principles and practice [M]. Philadelphia: Saunders, 1982:345-347.
  • 4FUJISHIMA H, SHIMAZAKI J, SHINOZAKI N, et al. Trabeculectomy with the use of amniotie membrane for uncontrollable glaueoma[J]. Ophthalmic Surg Lasers, 1998,29(5): 428-431.
  • 5DERICK R J, PASQUALE L, QUIGLEY H A, et al. Potential toxicity of mitomycin C[J]. Arch Ophthalmol, 1991,109 (12):1635
  • 6CHEN C W, HUANG H T, BAIR J S, et al. Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma[J]. J Ocular Pharmacol, 1990,6(3) : 175-182.
  • 7ORENGO-NANIA S, EL-HARAZI SM, ORAM O, et al. Effects of atropine on anterior chamber depth and anterior chamber inflammation after primary trabeeulectom [J]. J Glaucoma, 2000,9(4) : 303-310.
  • 8MIETZ H, JACOBI P C, KRIEGLSTEIN G K. Intraoperative episcleral versus postoperative topical application of mitomycin-C for trabeculectomies[J]. Ophthalmology, 2002,109 (7): 1343-1349.
  • 9孙兴怀.难治性青光眼的治疗[J].国外医学(眼科学分册),1995,19(1):26-31. 被引量:202
  • 10廖宇洁,许速,陈茜和.滤过性手术联合丝裂霉素C治疗难治性青光眼[J].眼科新进展,2002,22(6):438-439. 被引量:20

二级参考文献6

共引文献213

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部